Top

HAND

Published in:

01-12-2013 | Surgery Articles

Functional outcome of collagenase injections compared with fasciectomy in treatment of Dupuytren’s contracture

Author: Nash H. Naam

Published in: HAND | Issue 4/2013

Abstract

Background

This study was designed to provide comparative information on the safety and efficacy of injection with collagenase clostridium histolyticum (CCH) and fasciectomy for patients with Dupuytren’s contracture (DC).

Methods

A single-center, retrospective, observational, longitudinal chart review was conducted of 25 patients treated with CCH injections and 21 patients undergoing fasciectomy. Patients were assessed at 1 week, monthly for 3 months and then yearly for a minimum of 2 years after treatment for changes in contracture and range of motion, time to return to work/normal activities, patient satisfaction, and Disabilities of Arm, Shoulder and Hand (DASH) score.

Results

Post-procedure follow-up averaged 32 months for the injection group compared with 39 months for fasciectomy group. For the CCH group, the mean postinjection contracture was 3.6° for the metacarpophalangeal and 17.5° for the proximal interphalangeal joints compared with 3.7° and 8.1° in the fasciectomy group, respectively. Patients treated with injections returned to normal activities after a mean of 1.9 days compared with 37.4 days for fasciectomy patients (p < 0.0001). DASH scores for 13 CCH and 15 fasciectomy patients were obtained. The mean DASH score was significantly lower in the injection group in the first 3 months (p < 0.01). At the 2-year follow-up visit, patients were satisfied with their outcomes following either treatment (92 % and 96 % of CCH and fasciectomy patients, respectively).

Conclusion

CCH injections are safe and effective and may be a viable alternative to fasciectomy for treating DC. It also allows earlier return to work and daily activities.

Bainbridge C, Dahlin LB, Szczypa PP, Cappelleri JC, Guerin D, Gerber RA. Current trends in the surgical management of Dupuytren’s disease in Europe: an analysis of patient charts. Eur Orthop Traumatol. 2012;3:31–41.PubMedCrossRef

Becker GW, Davis TRC. The outcome of surgical treatments for primary Dupuytren’s disease—a systematic review. J Hand Surg Br. 2010;35:623–6.

Bulstrode NW, Jemec B, Smith PJ. The complications of Dupuytren’s contracture surgery. J Hand Surg Am. 2005;30:1021–5.PubMedCrossRef

Coert JH, Nerin JP, Meek MF. Results of partial fasciectomy for Dupuytren disease in 261 consecutive patients. Ann Plast Surg. 2006;57:13–7.PubMedCrossRef

Crean SM, Gerber RA, Hellio Le Graverand MP, Boyd DM, Cappelleri JC. The efficacy and safety of fasciectomy and fasciotomy for Dupuytren’s contracture in European patients: a structured review of published studies. J Hand Surg Br. 2011;36:396–407.

Denkler K. Surgical complications associated with fasciectomy for Dupuytren’s disease: a 20-year review of the English literature. Eplasty. 2010;10:116–33.

Desai SS, Hentz VR. Collagenase Clostridium histolyticum for Dupuytren’s contracture. Expert Opin Biol Ther. 2010;10:1395–404.PubMedCrossRef

Foucher G, Cornil C, Lenoble E. Open palm technique for Dupuytren’s disease. A five-year follow-up. Ann Chir Main Memb Super. 1992;11:362–6.PubMedCrossRef

Gilpin D, Coleman S, Hall S, Houston A, Karrasch J, Jones N. Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren’s disease. J Hand Surg Am. 2010;35:2027–38.PubMedCrossRef

10.

Herweijer H, Dijkstra PU, Nicolai JP, Van der Sluis CK. Postoperative hand therapy in Dupuytren’s disease. Disabil Rehabil. 2007;29:1736–41.PubMedCrossRef

11.

Hurst LC, Badalamente MA, Hentz VR, Hotchkiss RN, Kaplan FT, Meals RA, et al. Injectable collagenase clostridium histolyticum for Dupuytren’s contracture. N Engl J Med. 2009;361:968–79.PubMedCrossRef

12.

Jerosch-Herold C, Shepstone L, Chojnowski AJ, Larson D, Barrett E, Vaughan SP. Night-time splinting after fasciectomy or dermo-fasciectomy for Dupuytren’s contracture: a pragmatic, multi-centre, randomised controlled trial. BMC Musculoskelet Disord. 2011;12:136.PubMedCrossRef

13.

Mackin EJ, Skirven TM. Hand therapy. In: Tubiana R, Leclercq C, Hurst LC, et al., editors. Dupuytren’s disease. United Kingdom: Martin Dunitz, Ltd.; 2010:251–63.

14.

Mavrogenis AF, Spyridonos SG, Ignatiadis IA, Antonopoulos D, Papagelopoulos PJ. Partial fasciectomy for Dupuytren’s contractures. J Surg Orthop Adv. 2009;18:106–10.PubMed

15.

McGrouther DA. Dupuytren’s contracture. In: Green DP, Hotchkiss RN, Pederson WC, et al., editors. Green’s operative hand surgery. 5th ed. Philadelphia, PA: Elsevier Churchill Livingstone; 2005. p. 159–85.

16.

O’Gorman DB, Vi L, Gan BS. Molecular mechanisms and treatment strategies for Dupuytren’s disease. Ther Clin Risk Manage. 2010;6:383–90.

17.

Auxilium Pharmaceuticals, Inc. Xiaflex® (collagenase clostridium histolyticum) [prescribing information]. Malvern, PA: Auxilium Pharmaceuticals, Inc.; 2012.

18.

Rayan GM. Dupuytren’s disease: anatomy, pathology, presentation, and treatment. J Bone Joint Surg Am. 2007;89:189–98.PubMed

19.

Rayan GM. Nonoperative treatment of Dupuytren’s disease. J Hand Surg Am. 2008;33:1208–10.PubMedCrossRef

20.

Skrepnik NV, Waller P, Kushner H, Nguyen D. Collagenase Clostridium histolyticum therapy for Dupuytren's contracture in Europe, Australia and US. Presented at American Academy of Orthopaedic Surgeons 2011 Annual Meeting, February 15–19, 2011, San Diego, CA. Abstract 4601. Available at: http://www3.aaos.org/education/anmeet/anmt2011/proceedings.pdf. Accessed July 3, 2012.

21.

Thomas A, Bayat A. The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease. Ther Clin Risk Manage. 2010;6:557–72.

22.

Vigroux JP, Valentin P. A natural history of Dupuytren’s contracture treated by surgical fasciectomy: the influence of diathesis (76 hands reviewed at more than 10 years). Ann Chir Main Memb Super. 1992;11:367–74.PubMedCrossRef

23.

Wilson GR. Current surgical treatment of Dupuytren’s disease. Br J Clin Pract. 1997;51:106–10.PubMed

Title: Functional outcome of collagenase injections compared with fasciectomy in treatment of Dupuytren’s contracture
Author: Nash H. Naam
Publication date: 01-12-2013
Publisher: Springer US
Published in: HAND / Issue 4/2013
Print ISSN: 1558-9447
Electronic ISSN: 1558-9455
DOI: https://doi.org/10.1007/s11552-013-9540-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Functional outcome of collagenase injections compared with fasciectomy in treatment of Dupuytren’s contracture

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2013

Indications for microsurgical reconstruction of congenital hand anomalies by toe-to-hand transfers

Acute hand and wrist injuries sustained during recreational mountain biking: a prospective study

Volar capitate dislocation: a case report

Plating of metacarpal fractures with locked or nonlocked screws, a biomechanical study: how many cortices are really necessary?

The free fillet flap after traumatic amputation: a review of literature and case report

Treatment of chronic biceps tendon ruptures